US Patent 11919904 Sulfonylamide compounds as CDK2 inhibitors
Patent 11919904 was granted and assigned to Incyte on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+45 properties)
Article (+226 characters)
US Patent 11919904 Sulfonylamide compounds as CDK2 inhibitors
Article
Patent abstract
The present application provides sulfonyl amide compounds, which are inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alexander Sokolsky0
Liangxing Wu0
Margaret Favata0
Min Ye0
Sarah Winterton0
Wenqing Yao0
Yingnan Chen0
Yvonne Lo0
Date of Patent
March 5, 2024
0Patent Application Number
168328320
Date Filed
March 27, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11919904 Sulfonylamide compounds as CDK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
